Growth Hormone
HGH Somatropin
FDA Approved
Recombinant human growth hormone (191 aa). The upstream GH/IGF-1 axis activator. FDA-approved since 1985. Drives body composition, bone density, wound healing and metabolic function via JAK2/STAT5b.
Amino Acids191
Mol. Weight22,124 Da
Half-Life~4 hours (SC)
Availability
✅ In Stock
Amino Acid Sequence
191-amino acid single chain
What Is HGH Somatropin?
Human Growth Hormone (HGH / somatropin) is a 191-amino-acid single-chain polypeptide secreted by somatotroph cells of the anterior pituitary. Recombinant HGH (rHGH) has been FDA-approved since 1985 for GHD, Turner syndrome, Prader-Willi syndrome, CKD, and AIDS-related wasting.
Key Mechanisms
- JAK2 / STAT5b — primary signalling cascade driving hepatic IGF-1 production
- MAPK / ERK — cell proliferation, differentiation, anti-apoptotic effects
- PI3K / Akt / mTOR — protein synthesis, glucose uptake, cell survival
- Direct lipolysis — HSL activation in adipocytes shifts substrate use toward FFA
Research Applications
- GH/IGF-1 axis biology and body composition
- Bone density and osteoblast biology
- Wound healing and burn injury recovery
- Aging and anti-aging marker research
- Metabolic syndrome models
Key References
- Rudman D et al. “Effects of HGH in men over 60 years old.” N Engl J Med, 1990;323:1–6.
- Jorgensen JO et al. “Beneficial effects of GH treatment in GH-deficient adults.” Lancet, 1989;1:1221–1225.